8.85 USD
↗ 0.32 (3.71%)LIVE (AS OF 02:53 PM EDT)
REGENXBIO Inc.
RGNXNASDAQ • USD
Market: OPEN
Open?$8.53
High?$9.09
Low?$8.08
Prev. Close?$8.53
Volume?353.3K
Avg. Volume?906.7K
VWAP?$8.84
Rel. Volume?0.39x
Bid / Ask
Bid?$8.74 × 100
Ask?$8.86 × 100
Spread?$0.12
Midpoint?$8.80
Valuation & Ratios
Market Cap?440.3M
Shares Out?51.6M
Float?40.6M
Float %?80.2%
P/E Ratio?N/A
P/B Ratio?4.29
EPS?-$3.76
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?2.38Strong
Quick Ratio?2.38Strong
Cash Ratio?0.29Low
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUED
Score92/100
P/E?N/A▾
P/B?4.29FAIR▾
P/S?2.58CHEAP▾
P/FCF?N/A▾
EV/EBITDA?-2.8CHEAP▾
EV/Sales?2.38CHEAP▾
Returns & Efficiency
ROE?-188.7%WEAK▾
ROA?-42.8%WEAK▾
Cash Flow & Enterprise
FCF?$-126377000
Enterprise Value?$405.8M
Related Companies
Loading...
News
Profile
Regenxbio Inc is a clinical-stage biotechnology company focused on the development of gene therapy treatments. Its product candidates are designed to deliver genes to cells to address genetic defects or enable the production of therapeutic proteins. The company is developing a pipeline of investigational gene therapy treatments using its NAV Technology Platform based on adeno-associated virus (AAV) vectors. Its internal research and development programs are focused on therapies for retinal, neuromuscular, and neurodegenerative diseases.
Employees
371
Market Cap
440.3M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
Listed
2015-09-17
Address
9804 MEDICAL CENTER DRIVE
ROCKVILLE, MD 20850
Phone: 240-552-8181
ROCKVILLE, MD 20850
Phone: 240-552-8181